Recent Articles

November 20, 2017 12:58 pm
Ryan Bushey
A new discovery could be the key to creating personalized treatments for diabetes.
November 20, 2017 11:35 am
Joanne Van Zuidam
Through an agreement between Therapix Biosciences and Catalent Pharma Solutions, the two cannabinoids, THC and PEA, will be combined to develop the investigational drug THX-TS01 to address the symptoms of Tourette syndrome.
November 20, 2017 11:24 am
Joanne Van Zuidam
Through an agreement between Therapix Biosciences and Catalent Pharma Solutions, the two cannabinoids, THC and PEA, will be combined to develop the investigational drug THX-TS01 to address the symptoms of Tourette syndrome.
November 17, 2017 11:35 am
Joanne Van Zuidam
A meta-analysis of more than 3.4 million Swedes aged 40 to 80 found an association between owning a dog and living longer.
November 17, 2017 10:42 am
Ryan Bushey
Analysts predict one of the drugs could produce about $1.6 billion in annual sales by 2022.
November 16, 2017 4:34 pm
Ryan Bushey
The current study focused on sodium percarbonate (SPO) and calcium peroxide (CPO).
November 16, 2017 10:39 am
Joanne Van Zuidam
A Q&A with Dr. Geert Cauwenbergh, President and CEO, RXi Pharmaceticals
November 15, 2017 11:43 am
Joanne Van Zuidam
Cancer researchers at the University of Bergen (UiB) in Norway have discovered that a medication prescribed for parasites, such as tapeworms and giardia, contains a substance that kills prostate and colon cancer cells.
November 14, 2017 11:08 am
Joanne Van Zuidam
Will fructan-free be the next food trend? If a new study holds true, fructan, a carbohydrate found in wheat, will replace gluten as the guilty party in causing digestive distress in those with non-celiac wheat sensitivity.
November 14, 2017 9:51 am
Ryan Bushey
This is the first significant step emphasizing how healthcare and technology are beginning to converge.
Subscribe to Drug Discovery & Development